Aspira Women’s Health Inc. Deferred Tax Assets, in Process Research and Development
Aspira Women’s Health Inc. (AWHL) had Deferred Tax Assets, in Process Research and Development of $2.30 million as of 2025-12-31, per its 10-K filed 2026-04-01.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2026-04-01
- 2025-12-31: Deferred Tax Assets, in Process Research and Development $2.30M.
- 2024-12-31: Deferred Tax Assets, in Process Research and Development $3.12M.
- 2023-12-31: Deferred Tax Assets, in Process Research and Development $3.43M.
| Period end | Deferred Tax Assets, in Process Research and Development |
|---|---|
| 2025-12-31 | $2.30M 10-K · filed 2026-04-01 |
| 2024-12-31 | $3.12M 10-K · filed 2026-04-01 |
| 2023-12-31 | $3.43M 10-K · filed 2025-03-27 |